-
2022-502319-12-00
Alport syndrome 1 2023-05-30
-
2023-506824-96-00
The present study will include a population of patients 4 2023-05-23
-
2023-509747-27-00
Heart failure 4 2023-05-18
-
2023-508735-31-00
Pulmonary Arterial Hypertension (PAH) 5 2023-05-05
-
2022-502327-22-00
Healthy 3 2023-05-03
-
2022-502385-24-00
Heart failure with left ventricular ejection fraction ≥ 2 2023-04-27
-
2024-516374-29-00
Patients with excessive supraventricular ectopies or sh 11 2023-04-18
-
2024-519233-33-00
Cardioversion of paroxysmal atrial fibrillation in the 5 2023-04-13
-
2023-506352-24-00
Non-obstructive Hypertrophic Cardiomyopathy 5 2023-04-13
-
2024-514639-10-00
Acute Myocarditis 4 2023-03-30
-
2023-505902-40-00
Heart Failure with Preserved Ejection Fraction 4 2023-03-28
-
2024-514677-22-00
Restoration of sinus rhythm in patients with recent AF 5 2023-03-23
-
2022-501466-21-00
Lipoprotein Disorder 4 2023-03-01
-
2023-508860-31-00
Stage IV colon or rectal adenocarcinoma (mCRC). 5 2023-02-28
-
2024-512451-20-00
Patients with biopsy-proven virus-negative inflammatory 10 2023-02-28
-
2022-500347-20-00
Heart Failure 9 2023-02-23
-
2022-500301-41-00
Univentricular congenital heart disease with a Fontan-t 4 2023-02-20
-
2023-508831-29-00
Symptomatic Hypertrophic Cardiomyopathy and Left Ventri 4 2023-02-15
-
2024-517612-29-00
acute heart failure 11 2023-02-14
-
2022-501682-45-00
Heart failure with preserved ejection fraction 6 2023-02-13
-
2023-503793-20-00
Prevention of ischemic stroke in patients post acute no 5 2023-01-18
-
2024-511621-64-00
Acute kidney injury 4 2023-01-18
-
2022-500186-27-00
ATTR Amyloidosis 5 2023-01-11
-
2024-518551-37-00
Chronic thromboembolic pulmonary hypertension 4 2023-01-01